Pharmaceutical compositions

Details for Australian Patent Application No. 2005237266 (hide)

Owner Vectura Limited

Inventors Morton, David; Davies, Rebecca; Shott, Martin

Agent Allens Arthur Robinson

Pub. Number AU-B-2005237266

PCT Pub. Number WO2005/105043

Priority 0409703.6 30.04.04 GB

Filing date 29 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 11 November 2010

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105043 Priority application(s): WO2005/105043

11 November 2010 Application Accepted

  Published as AU-B-2005237266

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237267-An ostomy appliance

2005237256-MAGE-3 and NY-ESO-1 based polyvalent vaccine for cancer immunotherapy